These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1954989)

  • 1. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele.
    Milman N
    Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction between homozygous and heterozygous subjects with hereditary haemochromatosis using iron status markers and receiver operating characteristic (ROC) analysis.
    Milman N; Albeck MJ
    Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):95-8. PubMed ID: 7632826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA determinants in idiopathic haemochromatosis.
    Milman N; Graudal N; Nielsen LS; Sørensen SA
    Dan Med Bull; 1985 Oct; 32(5):262-4. PubMed ID: 4053696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes.
    Adams PC
    Am J Hematol; 1994 Feb; 45(2):146-9. PubMed ID: 8141120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes.
    de Valk B; Addicks MA; Gosriwatana I; Lu S; Hider RC; Marx JJ
    Eur J Clin Invest; 2000 Mar; 30(3):248-51. PubMed ID: 10692002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin, blood donation, iron stores and haemochromatosis.
    Worwood M; Darke C
    Transfus Med; 1993 Mar; 3(1):21-8. PubMed ID: 8038893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of haemochromatosis gene mutations in the general population: implications for screening.
    Burt MJ; George PM; Upton JD; Collett JA; Frampton CM; Chapman TM; Walmsley TA; Chapman BA
    Gut; 1998 Dec; 43(6):830-6. PubMed ID: 9824612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):171-7. PubMed ID: 9041480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype-genotype correlation in haemochromatosis subjects.
    Mura C; Nousbaum JB; Verger P; Moalic MT; Raguenes O; Mercier AY; Ferec C
    Hum Genet; 1997 Dec; 101(3):271-6. PubMed ID: 9439654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
    Bulaj ZJ; Griffen LM; Jorde LB; Edwards CQ; Kushner JP
    N Engl J Med; 1996 Dec; 335(24):1799-805. PubMed ID: 8943161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated serum ferritin and hemochromatosis in general practice].
    Mouland G; Bratland B; Hornnes MB; Asser HP; Lier J; Reiso H; Rygh E
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):20-2. PubMed ID: 15643457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene.
    Koziol JA; Ho NJ; Felitti VJ; Beutler E
    Clin Chem; 2001 Oct; 47(10):1804-10. PubMed ID: 11568090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases.
    Bell H; Skinningsrud A; Raknerud N; Try K
    J Intern Med; 1994 Sep; 236(3):315-22. PubMed ID: 8077889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.